Eurofins Proxy Laboratories BV Pharmadox Healthcare Ltd. Terapia S.A.

Poland

All drugs from this manufacturer

  • IKATYBANT RANBAXY

    The medicine is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and adolescents and children aged 2 years and older. It helps to stop the development of attack symptoms, such as swelling, pain, nausea, and diarrhea.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant 30 mg

    ATC: B06AC02